- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 11,412,557
- Total 13F shares
- 626,152
- Share change
- +9,263
- Total reported value
- $3,122,039
- Price per share
- $5.00
- Number of holders
- 12
- Value change
- +$20,311
- Number of buys
- 5
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 45175G207?
CUSIP 45175G207 identifies IMA - ImageneBio, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 45175G207:
Top shareholders of IMA - ImageneBio, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,116,569
|
$11,365,976 | — | 30 Mar 2021 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
7.2%
|
802,102
|
$6,538,736 | $0 | 30 Sep 2025 | |
| Blue Owl Capital Holdings LP |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
823,785
|
$5,684,117 | — | 31 Dec 2025 | |
| BVF INC/IL |
13F
|
Company |
7%
|
802,102
|
$5,534,504 | — | 31 Dec 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
5.6%
|
643,933
|
$4,443,138 | — | 31 Dec 2025 | |
| Funicular Funds, LP |
13D/G
|
— |
5.8%
|
643,933
|
$4,211,322 | $0 | 29 Dec 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
4%
|
455,361
|
$3,141,991 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
378,556
|
$2,612,036 | — | 31 Dec 2025 | |
| Stephen Hui Wang |
3/4/5
|
Director |
—
mixed-class rows
|
281,921
mixed-class rows
|
$2,329,197 | — | 18 Dec 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.9%
|
334,445
|
$2,307,671 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
238,000
|
$1,642,200 | — | 31 Dec 2025 | |
| GILEAD SCIENCES, INC. |
13D/G
|
— |
3.6%
|
1,521,312
|
$1,612,591 | $0 | 31 Dec 2024 | |
| Jonathan Jian Wang |
3/4/5
|
Director |
—
mixed-class rows
|
1,146,205
mixed-class rows
|
$1,494,105 | — | 18 Dec 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
1.6%
|
177,026
|
$1,221,479 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
131,587
|
$907,950 | — | 31 Dec 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.8%
|
91,621
|
$632,185 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.76%
|
86,478
|
$596,699 | — | 31 Dec 2025 | |
| Kristin Yarema |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
367,005
mixed-class rows
|
$567,056 | — | 16 Mar 2026 | |
| Otello Stampacchia |
3/4/5
|
Director |
4.1%
|
455,361
|
$482,681 | — | 25 Jul 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.58%
|
66,666
|
$459,995 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.58%
|
66,096
|
$456,062 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
54,146
|
$373,642 | — | 31 Dec 2025 | |
| NEA Management Company, LLC |
13F
|
Company |
0.44%
|
50,005
|
$345,035 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.42%
|
48,237
|
$332,835 | — | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.38%
|
43,768
|
$301,999 | — | 31 Dec 2025 | |
| Robert B. Lally |
3/4/5
|
Principal Accounting Officer |
0.52%
|
58,778
|
$293,890 | — | 20 Mar 2026 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.3%
|
34,228
|
$233,092 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.28%
|
31,884
|
$220,000 | — | 31 Dec 2025 | |
| Jotin Marango |
3/4/5
|
Chief Financial Officer |
0.1%
|
11,146
|
$191,265 | — | 25 Jul 2025 | |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P |
13F
|
Company |
0.23%
|
26,500
|
$182,850 | — | 31 Dec 2025 | |
| Erin Butler |
3/4/5
|
Principal Accounting Officer |
—
mixed-class rows
|
48,051
mixed-class rows
|
$167,103 | — | 30 Dec 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.2%
|
23,216
|
$160,190 | — | 31 Dec 2025 | |
| Aldebaran Capital, LLC |
13F
|
Company |
0.17%
|
19,070
|
$131,583 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.16%
|
18,727
|
$129,216 | — | 31 Dec 2025 | |
| Rangeley Capital, LLC |
13F
|
Company |
0.16%
|
18,244
|
$125,884 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.13%
|
14,896
|
$102,782 | — | 31 Dec 2025 | |
| Joseph P. Slattery |
3/4/5
|
Director |
—
mixed-class rows
|
47,200
mixed-class rows
|
$95,840 | +$95,840 | 24 Dec 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
13,495
|
$93,116 | — | 31 Dec 2025 | |
| T3 Companies, LLC |
13F
|
Company |
0.12%
|
13,200
|
$91,080 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
12,177
|
$84,021 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
11,454
|
$79,033 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
10,950
|
$75,555 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
10,797
|
$74,499 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
10,771
|
$74,320 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
4,961
|
$34,231 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
2,597
|
$17,919 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,000
|
$7,000 | — | 31 Dec 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
491
|
$3,389 | — | 31 Dec 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
400
|
$2,760 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
70
|
$483 | — | 31 Dec 2025 |
Institutional Holders of ImageneBio, Inc. - COMMON STOCK (IMA) as of Q1 2026
As of 31 Mar 2026,
ImageneBio, Inc. - COMMON STOCK (IMA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
626,152 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, HSBC HOLDINGS PLC, VANGUARD FIDUCIARY TRUST CO, Aldebaran Capital, LLC, JANE STREET GROUP, LLC, UBS Group AG, Vanguard Global Advisers, LLC, CITIGROUP INC, and WELLS FARGO & COMPANY/MN.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
40
Q1 2026 holders
12
Holder diff
-28
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.